Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase

Erik MüllersDepartment of Cell and Molecular Biology; Karolinska Institutet; Stockholm, SwedenView further author information

Helena Silva CascalesDepartment of Cell and Molecular Biology; Karolinska Institutet; Stockholm, SwedenView further author information

Himjyot JaiswalDepartment of Cell and Molecular Biology; Karolinska Institutet; Stockholm, SwedenView further author information

Adrian T SaurinDepartment of Medical Oncology and Department of Molecular Cancer Research; University Medical Center Utrecht; Utrecht, The Netherlands;Division of Cancer Research; Medical Research Institute; University of Dundee; Scotland, UKView further author information

Arne LindqvistDepartment of Cell and Molecular Biology; Karolinska Institutet; Stockholm, SwedenCorrespondence[email protected]
View further author information

Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase

Supplemental_Files

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase

Supplemental_Files

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date